Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Change in Receivables (2021 - 2026)

MoonLake Immunotherapeutics' Change in Receivables history spans 6 years, with the latest figure at $894000.0 for Q1 2026.

  • Quarterly Change in Receivables rose 512.33% to $894000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Mar 2026, up 85.73% year-over-year, with the annual reading at $2.0 million for FY2025, 13.38% up from the prior year.
  • Change in Receivables came in at $894000.0 for Q1 2026, up from $847000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $894000.0 in Q1 2026 to a low of -$383407.0 in Q4 2022.
  • The 5-year median for Change in Receivables is $336374.0 (2023), against an average of $330197.4.
  • Year-over-year, Change in Receivables tumbled 357.71% in 2022 and then surged 1083.98% in 2023.
  • MoonLake Immunotherapeutics' Change in Receivables stood at -$383407.0 in 2022, then soared by 187.73% to $336374.0 in 2023, then increased by 29.62% to $436000.0 in 2024, then soared by 94.27% to $847000.0 in 2025, then increased by 5.55% to $894000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Change in Receivables are $894000.0 (Q1 2026), $847000.0 (Q4 2025), and $612000.0 (Q3 2025).